Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 230

1.

A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).

Schloss JM, Colosimo M, Airey C, Masci P, Linnane AW, Vitetta L.

Support Care Cancer. 2017 Jan;25(1):195-204. Epub 2016 Sep 9.

PMID:
27612466
2.

Live probiotic cultures and the gastrointestinal tract: symbiotic preservation of tolerance whilst attenuating pathogenicity.

Vitetta L, Hall S, Linnane AW.

Front Cell Infect Microbiol. 2014 Oct 15;4:143. doi: 10.3389/fcimb.2014.00143. eCollection 2014.

3.

The overarching influence of the gut microbiome on end-organ function: the role of live probiotic cultures.

Vitetta L, Manuel R, Zhou JY, Linnane AW, Hall S, Coulson S.

Pharmaceuticals (Basel). 2014 Sep 19;7(9):954-89. doi: 10.3390/ph7090954. Review.

4.

Endocellular regulation by free radicals and hydrogen peroxide: key determinants of the inflammatory response.

Vitetta L, Linnane AW.

Inflammopharmacology. 2014 Apr;22(2):69-72. doi: 10.1007/s10787-014-0199-7. Epub 2014 Feb 22.

PMID:
24562527
5.
6.

Nutraceuticals and chemotherapy induced peripheral neuropathy (CIPN): a systematic review.

Schloss JM, Colosimo M, Airey C, Masci PP, Linnane AW, Vitetta L.

Clin Nutr. 2013 Dec;32(6):888-93. doi: 10.1016/j.clnu.2013.04.007. Epub 2013 Apr 13. Review. Erratum in: Clin Nutr. 2015 Feb;34(1):167.

PMID:
23647723
7.

The gastrointestinal microbiome and musculoskeletal diseases: a beneficial role for probiotics and prebiotics.

Vitetta L, Coulson S, Linnane AW, Butt H.

Pathogens. 2013 Nov 14;2(4):606-26. doi: 10.3390/pathogens2040606.

8.

My life as a biochemist and molecular biologist.

Linnane AW.

IUBMB Life. 2010 Jul;62(7):527-30. doi: 10.1002/iub.330. No abstract available.

9.

Age-related decline in stress responses of human myocardium may not be explained by changes in mtDNA.

Miller F, Nagley P, Mariani JA, Ou R, Liu VW, Zhang C, Linnane AW, Pepe S, Rosenfeldt F.

Mech Ageing Dev. 2009 Nov-Dec;130(11-12):742-7. doi: 10.1016/j.mad.2009.09.003.

PMID:
19819254
10.

Coenzyme Q(10)--its role as a prooxidant in the formation of superoxide anion/hydrogen peroxide and the regulation of the metabolome.

Linnane AW, Kios M, Vitetta L.

Mitochondrion. 2007 Jun;7 Suppl:S51-61. Epub 2007 Mar 30. Review.

PMID:
17482887
11.
12.

The essential requirement for superoxide radical and nitric oxide formation for normal physiological function and healthy aging.

Linnane AW, Kios M, Vitetta L.

Mitochondrion. 2007 Feb-Apr;7(1-2):1-5. Epub 2006 Dec 5. Review.

PMID:
17317335
13.
14.

Cellular redox poise modulation; the role of coenzyme Q10, gene and metabolic regulation.

Linnane AW, Eastwood H.

Mitochondrion. 2004 Sep;4(5-6):779-89. Epub 2004 Oct 2.

PMID:
16120432
15.
16.

Cellular redox activity of coenzyme Q10: effect of CoQ10 supplementation on human skeletal muscle.

Linnane AW, Kopsidas G, Zhang C, Yarovaya N, Kovalenko S, Papakostopoulos P, Eastwood H, Graves S, Richardson M.

Free Radic Res. 2002 Apr;36(4):445-53.

PMID:
12069109
17.
18.

Stochastic mitochondrial DNA changes: bioenergy decline in type I skeletal muscle fibres correlates with a decline in the amount of amplifiable full-length mtDNA.

Kopsidas G, Zhang C, Yarovaya N, Kovalenko S, Graves S, Richardson M, Linnane AW.

Biogerontology. 2002;3(1-2):29-36.

PMID:
12014837
19.

Age-related atrophy of rat soleus muscle is accompanied by changes in fibre type composition, bioenergy decline and mtDNA rearrangements.

Yarovaya NO, Kramarova L, Borg J, Kovalenko SA, Caragounis A, Linnane AW.

Biogerontology. 2002;3(1-2):25-7. Review.

PMID:
12014836
20.

The proteomics of ageing.

Cobon GS, Verrills N, Papakostopoulos P, Eastwood H, Linnane AW.

Biogerontology. 2002;3(1-2):133-6.

PMID:
12014833
21.

Human aging and global function of coenzyme Q10.

Linnane AW, Zhang C, Yarovaya N, Kopsidas G, Kovalenko S, Papakostopoulos P, Eastwood H, Graves S, Richardson M.

Ann N Y Acad Sci. 2002 Apr;959:396-411; discussion 463-5. Review.

PMID:
11976213
22.

Preferential amplification is minimised in long-PCR systems.

Kopsidas G, Kovalenko SA, Islam MM, Gingold EB, Linnane AW.

Mutat Res. 2000 Nov 30;456(1-2):83-8.

PMID:
11087899
23.

Tissue mitochondrial DNA changes. A stochastic system.

Kopsidas G, Kovalenko SA, Heffernan DR, Yarovaya N, Kramarova L, Stojanovski D, Borg J, Islam MM, Caragounis A, Linnane AW.

Ann N Y Acad Sci. 2000 Jun;908:226-43. Review.

PMID:
10911962
24.

Coenzyme Q10 improves the tolerance of the senescent myocardium to aerobic and ischemic stress: studies in rats and in human atrial tissue.

Rosenfeldt FL, Pepe S, Ou R, Mariani JA, Rowland MA, Nagley P, Linnane AW.

Biofactors. 1999;9(2-4):291-9.

PMID:
10416043
25.

Total extent and cellular distribution of mitochondrial DNA mutations in aging.

Kovalenko SA, Kelso J, Kopsidas G, Linnane AW.

Ann N Y Acad Sci. 1998 Nov 20;854:487. No abstract available.

PMID:
9928455
26.

The universality of bioenergetic disease. Age-associated cellular bioenergetic degradation and amelioration therapy.

Linnane AW, Kovalenko S, Gingold EB.

Ann N Y Acad Sci. 1998 Nov 20;854:202-13. Review.

PMID:
9928431
27.

Tissue-specific distribution of multiple mitochondrial DNA rearrangements during human aging.

Kovalenko SA, Kopsidas G, Kelso J, Rosenfeldt F, Linnane AW.

Ann N Y Acad Sci. 1998 Nov 20;854:171-81. Review.

PMID:
9928428
28.

The age-associated decrease in the amount of amplifiable full-length mitochondrial DNA in human skeletal muscle.

Kovalenko SA, Kopsidas G, Islam MM, Heffernan D, Fitzpatrick J, Caragounis A, Gingold E, Linnane AW.

Biochem Mol Biol Int. 1998 Dec;46(6):1233-41. Erratum in: Biochem Mol Biol Int 1999 Jun;47(6):1097.

PMID:
9891857
29.

Coenzyme Q10 treatment improves the tolerance of the senescent myocardium to pacing stress in the rat.

Rowland MA, Nagley P, Linnane AW, Rosenfeldt FL.

Cardiovasc Res. 1998 Oct;40(1):165-73.

PMID:
9876329
30.

An age-associated correlation between cellular bioenergy decline and mtDNA rearrangements in human skeletal muscle.

Kopsidas G, Kovalenko SA, Kelso JM, Linnane AW.

Mutat Res. 1998 Oct 12;421(1):27-36.

PMID:
9748486
31.

Differential occurrence of mutations in mitochondrial DNA of human skeletal muscle during aging.

Zhang C, Liu VW, Addessi CL, Sheffield DA, Linnane AW, Nagley P.

Hum Mutat. 1998;11(5):360-71. Erratum in: Hum Mutat 1998;12(1):69.

PMID:
9600454
32.

Deltoid human muscle mtDNA is extensively rearranged in old age subjects.

Kovalenko SA, Kopsidas G, Kelso JM, Linnane AW.

Biochem Biophys Res Commun. 1997 Mar 6;232(1):147-52.

PMID:
9125120
33.

Proton pumping of mitochondrial complex I: differential activation by analogs of ubiquinone.

Helfenbaum L, Ngo A, Ghelli A, Linnane AW, Degli Esposti M.

J Bioenerg Biomembr. 1997 Feb;29(1):71-80.

PMID:
9067804
34.

Varied prevalence of age-associated mitochondrial DNA deletions in different species and tissues: a comparison between human and rat.

Zhang C, Bills M, Quigley A, Maxwell RJ, Linnane AW, Nagley P.

Biochem Biophys Res Commun. 1997 Jan 23;230(3):630-5.

PMID:
9015375
35.

Method for in situ investigation of mitochondrial DNA deletions.

Kovalenko SA, Harms PJ, Tanaka M, Baumer A, Kelso J, Ozawa T, Linnane AW.

Hum Mutat. 1997;10(6):489-95.

PMID:
9401014
37.

The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria.

Esposti MD, Ngo A, Ghelli A, Benelli B, Carelli V, McLennan H, Linnane AW.

Arch Biochem Biophys. 1996 Jun 15;330(2):395-400.

PMID:
8660670
38.

Comparison of different quantitative PCR procedures in the analysis of the 4977-bp deletion in human mitochondrial DNA.

Zhang C, Peters LE, Linnane AW, Nagley P.

Biochem Biophys Res Commun. 1996 Jun 14;223(2):450-5.

PMID:
8670302
39.

Characterisation of the tumour-associated carbohydrate epitope recognised by monoclonal antibody 4D3.

Pinczower GD, Williams RP, Gianello RD, Robinson HC, Preston BN, Linnane AW.

Int J Cancer. 1996 May 29;66(5):636-44.

40.

The specificity of mitochondrial complex I for ubiquinones.

Degli Esposti M, Ngo A, McMullen GL, Ghelli A, Sparla F, Benelli B, Ratta M, Linnane AW.

Biochem J. 1996 Jan 1;313 ( Pt 1):327-34.

41.

The universality of bioenergetic disease and amelioration with redox therapy.

Linnane AW, Degli Esposti M, Generowicz M, Luff AR, Nagley P.

Biochim Biophys Acta. 1995 May 24;1271(1):191-4.

42.

Unusual pattern of mitochondrial DNA deletions in skeletal muscle of an adult human with chronic fatigue syndrome.

Zhang C, Baumer A, Mackay IR, Linnane AW, Nagley P.

Hum Mol Genet. 1995 Apr;4(4):751-4. No abstract available.

PMID:
7633428
43.

Constitutive and virus-induced interferon production by peripheral blood leukocytes.

Greenway AL, Hertzog PJ, Devenish RJ, Linnane AW.

Exp Hematol. 1995 Mar;23(3):229-35.

PMID:
7875240
44.
45.

Up-regulation of the plasma membrane oxidoreductase as a prerequisite for the viability of human Namalwa rho 0 cells.

Larm JA, Vaillant F, Linnane AW, Lawen A.

J Biol Chem. 1994 Dec 2;269(48):30097-100.

46.

Immunolocalisation of interferon-alpha in hepatitis C patients and its correlation with response to interferon-alpha therapy.

Greenway AL, Hertzog PJ, Devenish RJ, Dudley FJ, McMullen GL, Linnane AW.

J Hepatol. 1994 Nov;21(5):842-52.

PMID:
7890902
47.

Detection of interferon-alpha expression by PCR in patients with chronic hepatitis C and hepatitis non-A, non-B.

Brandt ER, Devenish RJ, Hertzog PJ, Dudley FJ, Linnane AW.

J Gastroenterol Hepatol. 1994 Jul-Aug;9(4):373-80.

PMID:
7948820
48.

cDNA sequence identity for the type I interferon receptor subunit from cell lines of widely differing responsiveness to interferon.

Payne MJ, Ralph SJ, De Veer MJ, Allen K, Linnane AW, Devenish RJ.

Biochem Mol Biol Int. 1994 May;33(2):283-8.

PMID:
7951047
49.
50.

Expression of IFN A genes in subpopulations of peripheral blood cells.

Brandt ER, Linnane AW, Devenish RJ.

Br J Haematol. 1994 Apr;86(4):717-25.

PMID:
7918063

Supplemental Content

Loading ...
Support Center